Halozyme Therapeutics, Inc.HALONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.5%
5Y CAGR+33.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+10.5%/yr
vs +24.0%/yr prior
5Y CAGR
+33.4%/yr
Recent deceleration
Acceleration
-13.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $193.39M | +25.3% |
| 2024 | $154.34M | +3.5% |
| 2023 | $149.18M | +3.9% |
| 2022 | $143.53M | +185.2% |
| 2021 | $50.32M | +10.0% |
| 2020 | $45.74M | -40.8% |
| 2019 | $77.25M | +27.1% |
| 2018 | $60.80M | +13.0% |
| 2017 | $53.82M | +17.4% |
| 2016 | $45.85M | - |